Introduction: Osteoarthritis (OA) is the most common form of arthritis characterized by the degeneration of articular cartilage, intra-articular inflammation, and osteophytes formation. Notably, OA chondrocytes undergo cellular changes that recall hypertrophy and ossification process of the growth plate chondrocytes during endochondral ossification. This "replay" at incorrect time and incorrect location leads to subchondral bone pathological process and ossification (osteophytes formation). Therefore, logically, many genes, including HIF-2a, Runx2 and Hedgehog pathway, regulate the developmental endochondral ossification, may also affect the osteophytes formation in OA pathology. Wnt signaling pathway, one of the crucial pathways, regulates chondrocyte differentiation during embryonic development and after birth. Our preliminary data suggests that Wnt16, the last member of Wnt family currently, regulates cartilage differentiation during embryonic mouse endochondral ossification. We hypothesize that Wnt16 attenuates OA progression by inhibiting chondrocytes hypertrophy and osteophytes formation. Our study aims to investigate the function of Wnt16 in OA pathology and its potential for OA therapy.
Methods: The function of Wnt16 during embryonic skeleton development was examined by whole-mount alizarin red and alcian blue staining in the newborn of the ColIIa-creWnt16 flox/flox conditional knockout (cKO) and wild type (WT) mice respectively. Male mice from these two groups at 2 months of age were undergo OA model surgery, and Ad-Wnt16 or Ad-Wnt16-shRNA was intra-articular injected after OA model surgery. Samples were collected at designed time points (Week 2, 4, 6 and 8) for mCT and histological evaluation of the OA progression. The mechanism exploration was mainly performed in vitro by Q-PCR and western blotting to detect the gene expression under Ad-Wnt16 or Ad-Wnt16-shRNA stimulation, and the results were confirmed by histological staining. Results were expressed as mean AE standard deviation. Statistical analysis was carried out using two-way ANOVA with Sidaks multiple comparisons test. P values of less than 0.05 were considered statistically significant. Results: Wnt16 knockout did not affect the embryonic skeleton development. However, mCT and histological analysis showed the cKO mice developed much severer OA compared to the WT mice. Moreover, intra-articular injection of AdWnt16 significantly inhibited the OA process. For the mechanism exploration, we discovered that many cartilage markers, including ColIIa, aggrecan, SOX9 and Has2, were significantly decreased by IL-1b while promoted by Wnt16. However, parathyroid hormone (PTH) pathway, which can inhibit chondrocytes hypertrophy, was significantly decreased by IL-1b when Wnt16 absence, and significantly promoted by Ad-Wnt16 both showed by Q-PCR and western blotting, and confirmed by histological detection. Discussion: In our current study, we showed a cartilage protective function of Wnt16 and a potential target for OA therapy. Most studies in this field have focused on blocking molecules that cause cartilage destruction. However, we now demonstrate new ways by applying the tools that nature itself uses to protect cartilage from injury. The OA protective role of Wnt16 suggest it as a potential target for OA therapy and future development of strategies to deliver Wnt16 to joints may prevent severe and permanent disability in patients suffering from cartilage loss. Background: Chondrosarcoma is the second common primary malignant bone tumor and characterized by secreting cartilage-like matrix to extracellular environment. Primary cilia is a microtubule-based organelle and functions as "antenna" to detect various stimulus in extracellular environment. Recently, primary cilia is found to be absent in chondrosarcoma but the mechanical of deciliation remains unclear. Histone deacetylases 6 (HDAC6), as a special enzyme to regulate proteins acetylated modification, can deacetylate a-tubulin which is the main structure of primary cilia. In this manuscript, we try to evaluate the role of HDAC6 in regulating chondrosarcoma cell malignant properties and primary cilia expression. Subjects and Methods: Immunohistochemical assay was used to detect the expression of HDAC6 and primary cilia related Hedgehog pathway proteins in chondrosarcoma tissues. CCK8 cell viability test, transwell and vasculogenic mimic assays were conducted to detect the influences of inhibiting HDAC6 by using inhibitor Tubastatin A and small interfering RNA(siRNA 
